|
|
| |
|
|
| |
|
MIT Alumni Profile
Ad Series
|
| |
 |
|
BioTrove,
Inc. |
|
|
“Cummings
Properties converted a 20,000 square foot office space to
a top of the line, fully functional biotech facility in just
60 days. It was unbelievable how quickly the construction
was completed. As a result, we experienced no down time as
we moved into 12 Gill Street.”
Colin
Brenan, Ph.D.
President and C.E.O.
|
|
| BioTrove
is an early stage biotech company commecializing micro and nanotechnology
for applications in genomics, genetics and drug discovery. The
company moved from Cambridge, MA, where it was founded by five
scientists from the Department of Mechanical Engineering
at MIT |
|
|
| |
 |
|
Boston
Microsystems |
|
|
“Cummings
Properties is the perfect alternative to Cambridge. More desirable
rates, a quick and professional buildout and unparalleled
service more than satisfied our leasing needs.”
Dr. Richard
Mlcak
President
Doctor of Science
MIT, 1994
|
|
| Boston
MicroSystems provides robust, miniaturized sensor platforms
to meet today’s demanding detection needs. Their technologies
enable a portfolio of highly stable, harsh environment compatible
microsensors that are optimized for environmental monitoring,
personnel safety, homeland defense, industrial process control,
and quality control applications. |
|
|
| |
 |
|
| Brontes
Technologies |
|
“Cummings
Properties were very responsive to a reference from
the MIT Venture Mentoring Center and provided us with
a flexible start-up-friendly real estate deal.”
|
|
| |
| Brontes
Technologies has pioneered a new form of 3D imaging based on
Active Wavefront Sampling (AWS). The AWS technique enables both
high-accuracy and high-speed 3D imaging with a single lens device.
Brontes’
patented technology, developed over the past four years at
MIT, has generated significant interest from leaders
in both industry and academia. Brontes was a Finalist at the
Massachusetts Institute of Technology 50K Competition,
a recipient of the prestigious Deshpande Center grant at MIT,
and now has its growing corporate headquarters at 400 West
Cummings Park in Woburn.
|
|
|
| |
 |
|
Lilliputian
Systems,
Inc. |
|
|
“
As a start-up firm, we needed a small centrally located office
and lab available for immediate occupancy. We also needed
the option of expanding the facility. Very few real estate
firms have all the in-house capabilities to provide this product,
but Cummings Properties’ Emerging Technology Centers
were a perfect fit.”
Aleksander Franz
Founder
|
|
| Lilliputian
Systems, Inc. is developing a next generation micro fuel cell
system for portable electronics and wireless applications. These
fuel cells can provide a significantly longer run time than
traditional batteries and are environmentally friendly. The
company employs a proprietary MEMS-based technology developed
by the founders at the world-class Microsystems Technology
Laboratories at MIT. |
|
|
| |
 |
|
Natural
Pharmaceuticals, Inc. |
|
|
“Cummings
Center has attracted a mini-cluster of biotech and pharmaceutical
companies which in turn has attracted a range of professional
services that was very attractive to us.”
Roland
R. Franke, Ph.D.
Co-Chief Executive Officer
M.S./MBA from the Sloan School of Management,
MIT, 1995
|
|
| Natural
Pharmaceuticals, Inc. (NPI) produces a dependable supply of
high-purity, semi-synthetic paclitaxel at competitive prices
for the global market. Additionally, NPI provides customers
with technical, regulatory, and analytical support. |
|
|
| |
 |
|
| Smartcells |
|
“Cummings
was an easy choice. They are one of the only firms in
the Boston area offering high quality lab space in sizes
that start-ups like ours can afford.”
Todd
Zion,
President & CEO, MIT Ph.D. candidate
|
|
| |
SmartCells,
winner of the 2003 MIT $50K Entrepreneurship Competition,
has developed a polymer-based dosing technology for auto-regulating
the release of a therapeutic based on the plasma concentration
of a molecular indicator. Its lead application, SmartInsulin
for diabetes, has a market potential of over $5 billion. The
team includes a tenured professor and Ph.D. candidate from
MIT’s Chemical Engineering department (the founders)
and two world-renowned diabetes experts (scientific advisors).
|
|
|
| |
|
|
